Hybryte™疗法研究成果将于2026年美国皮肤淋巴瘤联盟年度研讨会公布

美股速递
Mar 23

Soligenix, Inc. 旗下Hybryte™疗法的临床研究成果,已确认将于2026年美国皮肤淋巴瘤联盟年度研讨会上正式发布。这一重要数据的公布,预示着该创新疗法在皮肤淋巴瘤治疗领域的最新进展将获得行业权威平台的集中展示。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10